CROS NT srl-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:CROS NT srl - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013089
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CROS NT srl (CROS NT) is a contract research organization (CRO), which specializes in clinical data management, analysis, reporting and technologies. Its services include programming, analysis, medical writing, CROS academy training, methodology and clinical data management. Its outsourcing solutions include centralized clinical data and it adopts the functional service provider model. The company employs technologies such as EDC Solutions, IWRS, ePRO, CTMS and Data Visualization. CROS NT’s services span a very wide range of therapeutic areas and indications. The company provides its services to pharmaceutical, biotechnology, medical device sectors and academic institutions, associations and other CROs. CROS NT operates in Germany, the US and the UK and is headquartered in Verona, Italy.

CROS NT srl – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CROS NT srl, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CROS NT srl, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CROS NT srl, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CROS NT srl, Medical Devices Deals, 2011 to YTD 2017 8
CROS NT srl, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
CROS NT srl, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Cros NT Acquires Symphony EDC System From Powertrial 10
Partnerships 11
CROS NT Extends Partnership with DATATRAK International 11
Acquisition 12
CROS NT Acquires MDSL International, Contract Research Organization 12
Cros NT To Acquire Stat-Tech Services, Contract Research Organization 13
CROS NT srl – Key Competitors 14
CROS NT srl – Key Employees 15
CROS NT srl – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
May 30, 2017: Mark Paul appointed President of CROS NT 17
Product News 18
Feb 24, 2017: CROS NT Published in Journal of Clinical Oncology for Phase III Breast Cancer Trial 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
CROS NT srl, Pharmaceuticals & Healthcare, Key Facts 2
CROS NT srl, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
CROS NT srl, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CROS NT srl, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CROS NT srl, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CROS NT srl, Medical Devices Deals, 2011 to YTD 2017 8
CROS NT srl, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cros NT Acquires Symphony EDC System From Powertrial 10
CROS NT Extends Partnership with DATATRAK International 11
CROS NT Acquires MDSL International, Contract Research Organization 12
Cros NT To Acquire Stat-Tech Services, Contract Research Organization 13
CROS NT srl, Key Competitors 14
CROS NT srl, Key Employees 15
CROS NT srl, Other Locations 16
CROS NT srl, Subsidiaries 16

★海外企業調査レポート[CROS NT srl-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Statoil ASA (STL)-エネルギー分野:企業M&A・提携分析
    Summary Statoil ASA (Statoil) is an independent upstream oil and gas company. The company explores for, develops and produces oil and gas from its assets across the world, and trades crude oil and natural gas. The company operates assets in Norwegian Continental Shelf (NCS), which includes the North …
  • Genome British Columbia:医療機器:M&Aディール及び事業提携情報
    Summary Genome British Columbia (Genome BC) is a non-profit medical research organization that conducts genomics and proteomics research, and offers science and technology solutions. The organization provides prognostic, new diagnostic, and therapeutic tools for use in personalized medicine. It also …
  • bioLytical Laboratories Inc:企業の製品パイプライン分析
    Summary bioLytical Laboratories Inc (bioLytical) operates as a medical device company that develops and manufactures HIV diagnostic products. The company provides products such as insti HIV-1 and HIV-2 antibody test and insti HIV-1 and HIV-2 test controls. Its product line offers test result that tr …
  • AMETEK, Inc.:企業の戦略・SWOT・財務情報
    AMETEK, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMETEK, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Global Marine Systems Ltd:電力:M&Aディール及び事業提携情報
    Summary Global Marine Systems Limited (Global Marine), a subsidiary of Bridgehouse Marine Limited, is a marine technology and engineering company. It provides submarine cable installation, maintenance and engineering services. Its capabilities include project management, subsea cable installation, s …
  • Landis+Gyr AG (LAND):企業の財務・戦略的SWOT分析
    Landis+Gyr AG (LAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Chiome Bioscience Inc (4583)-製薬・医療分野:企業M&A・提携分析
    Summary Chiome Bioscience Inc (Chiome Bioscience) is a healthcare service company that offers research and development of therapies. The company research and develops antibody drugs for the treatment of autoimmune and inflammatory diseases. Its ADLib system is a monoclonal antibody generating system …
  • Green Plains Inc (GPRE):企業の財務・戦略的SWOT分析
    Green Plains Inc (GPRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Cheng Loong Corp:企業の戦略・SWOT・財務情報
    Cheng Loong Corp - Strategy, SWOT and Corporate Finance Report Summary Cheng Loong Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Mylan Laboratories Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Mylan Laboratories Ltd (Mylan), a subsidiary of Mylan NV is a pharmaceutical company that manufactures and supplies API products. The company offers HIV care products for the treatment of HIV/AIDS. It provides women’s care products for therapies such as hormone replacement therapy, infertili …
  • P/F Atlantic Petroleum (ATLA DKK):企業の財務・戦略的SWOT分析
    Summary P/F Atlantic Petroleum (Atlantic Petroleum) is an oil and gas company that offers development of offshore oil projects. The company's services include exploration, appraisal, development, and production programs. It operates its oil and gas interests in the Norwegian Continental Shelf, the U …
  • Instituto Costarricense de Electricidad:電力:M&Aディール及び事業提携情報
    Summary Instituto Costarricense de Electricidad (ICE) is an autonomous institution of the Government of Costa Rica that provides electricity and telecommunications services. The company generates, transmits and distributes electricity; and constructs, operates, and maintains power plants. It uses cl …
  • Odebrecht SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Odebrecht S.A. (Odebrecht) is a diversified company. It carries out engineering and infrastructure construction services, development and operation of energy and infrastructure projects and real estate development services. The company executed various engineering and construction projects s …
  • Hagoromo Foods Corp:企業の戦略・SWOT・財務分析
    Hagoromo Foods Corp - Strategy, SWOT and Corporate Finance Report Summary Hagoromo Foods Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Chiesi USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Chiesi USA Inc (Chiesi USA), a specialty pharmaceutical company, is a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. The company researches, develops, produces and commercializes innovative products in the areas such as cardiovascular, respiratory, neonatology, rare disease and specia …
  • Nippon Kayaku Co Ltd (4272):製薬・医療:M&Aディール及び事業提携情報
    Summary Nippon Kayaku Co Ltd (Nippon Kayaku) is a chemical company, which undertakes the development, manufacturing and sale of functional chemicals, pharmaceuticals and safety systems. The company's product portfolio includes epoxy resins, UV-curing type resins, optical functional films, colors for …
  • Dr. August Oetker KG:戦略・SWOT・企業財務分析
    Dr. August Oetker KG - Strategy, SWOT and Corporate Finance Report Summary Dr. August Oetker KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Specialist Investment Properties PLC:企業の戦略・SWOT・財務情報
    Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report Summary Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Smiths Group Plc (SMIN):企業の財務・戦略的SWOT分析
    Smiths Group Plc (SMIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Modern Times Group MTG AB:企業の戦略・SWOT・財務分析
    Modern Times Group MTG AB - Strategy, SWOT and Corporate Finance Report Summary Modern Times Group MTG AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆